Olomouc study reveals how many have COVID antibodies
NCT ID NCT07387211
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at nearly 2,500 adults in the Olomouc region to find out how many had antibodies or cellular immunity against the SARS-CoV-2 virus, either from a past infection or from vaccination. Participants gave blood samples and answered a questionnaire. The goal was to understand the level of protection in the community, not to test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARS-COV-2 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Hospital Olomouc
Olomouc, 77900, Czechia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new pill keep High-Risk COVID-19 patients out of the hospital?
- Could a five-day pill course cut COVID-19 deaths? czech nationwide data puts molnupiravir to the test.
- Millions of vaccine records scoured for rare side effects
- Scientists probe why lung disease raises COVID-19 risk
- New rapid test could spot COVID and flu in minutes
- New saliva test could diagnose COVID-19 in under an hour